Scientist who has studied and published in the field lacks standing to challenge EU medicines approval: judgment

十二月 19, 2003

Luxembourg, 18 December 2003

T-326/99, Nancy Fern Olivieri v Commission of the European Communities and European Agency for the Evaluation of Medicinal Products

Judgment of the Court of First Instance (Fifth Chamber) on 18 December 2003 (link to English version when available). Full text

Medicinal product - Marketing authorisation - Opinion of the European Agency for the Evaluation of Medicinal Products - Admissibility - Interest in bringing proceedings - Public health - Verification of reported data - Review of scientific evaluations - Professional reputation

The Court ruled:

1. Dismisses the application as inadmissible;

2. Orders the applicant to bear her own costs and to pay those incurred by the Commission and the European Agency for the Evaluation of Medicinal Products, including those relating to the interim proceedings;

3. Orders the intervener to bear its own costs, both in the main proceedings and in the interim proceedings.

European Court of First Instance, judgment 18 December 2003

请先注册再继续

为何要注册?

  • 注册是免费的,而且十分便捷
  • 注册成功后,您每月可免费阅读3篇文章
  • 订阅我们的邮件
注册
Please 登录 or 注册 to read this article.